QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 abvc-biopharma-collaboration-between-abvc-and-oncox-biopharma-abvc-expecting-aggregate-income-of-1375m-and-royalties-of-up-to-1250m-grants-oncox-exclusive-rights-for-one-of-abvcs-four-products-in-its-oncology-pipeline-to-develop-manufacture-commercialize-blex-404

https://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390024041053/ea0205569-8k_abvcbio.htm

 aibtl-biopharma-inc-acquired-tt-life-company-valued-at-833m-with-166m-aibtl-shares-at-5-per-share

ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solut...

 abvc-biopharma-executes-a-global-licensing-definitive-agreement-for-the-treatment-of-nsclc-expecting-aggregate-income-of-1375m-and-royalties-of-up-to-1250m

ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solut...

Core News & Articles
Market-Moving News for April 10th
04/10/2024 12:39:39

ADIL: 108% | Adial Pharmaceuticals shares are trading higher after the company announced the publication of a peer-reviewed art...

 abvc-biopharma-executes-a-global-licensing-term-sheet-for-oncologyhematology-products-expecting-licensing-income-of-55m-and-royalties-of-up-to-50m

 ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solu...

 why-abvc-biopharma-stock-is-up-today

ABVC BioPharma said that the licensing agreement includes the ophthalmology pipeline, including the medical device Vitargus lic...

 abvc-biopharma-provides-fiscal-year-2024-q1-business-update

ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a biotechnology company specializing in botanically based solutions tha...

 abvcs-new-horizon-for-oncology-and-hematology-aims-at-cancer-market

 ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solu...

 why-mobileye-global-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION